Control eyes (n=40) | BRVO patients (n=40) | p value | ||||
---|---|---|---|---|---|---|
Affected eyes | Unaffected fellow eyes | Affected vs control † | Unaffected fellow vs control † | Affected vs unaffected fellow †† | ||
SER (D) | 0.70±1.41 | 0.89±1.51 | 0.95±1.65 | 0.606 | .520 | 0.757 |
AL (mm) | 23.48±0.68 | 22.99±0.56 | 23.09±0.51 | 0.001* | 0.005* | 0.052 |
Disc area (mm2) | 1.88 ± 0.22 | 1.84 ±0.30 | 1.87 ±0.34 | 0.491 | 0.873 | 0.482 |
Cup area (mm2) | 0.54 ± 0.31 | 0.51±0.39 | 0.55±0.45 | 0.692 | 0.911 | 0.423 |
Rim area (mm2) | 1.31 ± 0.30 | 1.33±0.38 | 1.34±0.47 | 0.727 | 0.697 | 0.901 |
Rim V (mm3) | 0.16±0.07 | 0.20±0.18 | 0.18±0.12 | 0.166 | 0.338 | 0.421 |
Cup V (mm3) | 0.07±0.08 | 0.07±0.09 | 0.09±0.12 | 0.880 | 0.511 | 0.509 |
CDaR | 0.30±0.18 | 0.27±0.19 | 0.29±0.22 | 0.485 | 0.796 | 0.492 |
hCDR | 0.55±0.22 | 0.51±0.24 | 0.52±0.27 | 0.402 | 0.602 | 0.582 |
vCDR | 0.47±0.16 | 0.47±0.23 | 0.46±0.25 | 0.978 | 0.907 | 0.878 |
aveRNFL (μm) | 100.64±7.38 | 100.86±11.09 | 101.13±9.26 | 0.918 | 0.796 | 0.879 |